Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Antifungals from Schering-Plough

Feb. 20, 1997

U.S. researchers prepare chloroquine analogues

Feb. 19, 1997

Magainin lead product licensed to SKB

Feb. 17, 1997

Vaginal antifungal product cleared by FDA

Feb. 17, 1997

Neuraminidase inhibitor holds promise for flu

Feb. 14, 1997

Milestone achieved in Microcide/Pfizer collaboration

Feb. 10, 1997

Antifungal agent revealed by Bayer

Feb. 10, 1997

Japanese researchers describe triazole antifungals

Feb. 7, 1997

Rockefeller University discloses antibiotic peptides

Feb. 7, 1997

Another approval for first-line Abelcet

Feb. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 29, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 29, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...